Research advances on microRNAs in colorectal cancer

doi:10.3877/cma.j.issn.2095-3224.2012.01.01

Abstract

Abstract:

MicroRNAs (miRNAs) are a class of endogenous, noncoding small RNAs, 22nt in length. Repressing the translation and inducing the degradation of target miRNAs genes by binding to the 3’-UTR participate in regulating multiple physiological and pathological processes. Many recent research implicates that miRNAs play oncogenic and tumor suppressor role in the initiation and progression of colorectal cancer. Thus, miRNAs are suggested as important markers in diagnosing and treating colorectal cancer. Colorectal cancer is one of intestinal tumor with high morbidity and mortality. This article reviews the recent research advances on molecular mechanism, diagnosis, treatment and drug resistance of miRNAs in colorectal cancer.

Key words: MicroRNAs, Colorectal neoplasms, Early diagnosis, Prognosis

Bao-feng YANG. Research advances on microRNAs in colorectal cancer[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2012, 01(01): 1-5.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhjzcjbdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3224.2012.01.01

https://zhjzcjbdzzz.cma-cmc.com.cn/EN/Y2012/V01/I01/1

Figures/Tables 1

References 44

[1]	Jemal A,Siegel R,Xu J,Ward E, et al.Cancer statistics, 2010[J]. CA Cancer J Clin, 2010, 60(5): 277-300.
[2]	Yang L,Parkin DM,Li L, et al.Time trends in cancer mortality in China：1987-1999[J]. Int J Cancer, 2003, 106(5): 771-783.
[3]	Inui M,Martello G,Piccolo S, et al.MicroRNA control of signal transduction[J]. Nat Rev Mol Cell Biol, 2010, 11(4): 252-263.
[4]	Lujambio A,Lowe SW.The microcosmos of cancer[J]. Nature, 2012, 482(7385): 347-355.
[5]	Hanahan D,Weinberg RA.Hallmarks of cancer：the next generation[J]. Cell, 2011, 144(5): 646-674.
[6]	Ruan K,Fang X,Ouyang G. MicroRNAs：novel regulators in the hallmarks of human cancer[J]. Cancer Lett, 2009, 285(2): 116-126.
[7]	Akao Y,Nakagawa Y,Naoe T. Let-7 microRNA functions as a potential growth suppressor in human colon cancer cells[J]. Biol Pharm Bull, 2006, 29(5): 903-906.
[8]	Chen X,Guo X,Zhang H, et al.Role of miR-143 targeting KRAS in colorectal tumorigenesis[J]. Oncogene, 2009, 28(10): 1385-1392.
[9]	Tazawa H,Tsuchiya N,Izumiya M, et al.Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells[J]. Proc Natl Acad Sci U S A, 2007, 04(39): 15472-15477.
[10]	Liu M,Lang N,Qiu M, et al.miR-137 targets Cdc42 expression, induces cell cycle G1 arrest and inhibits invasion in colorectalcancer cells[J]. Int J Cancer, 2011, 128(6): 1269-1279.
[11]	Sun JY,Huang Y,Li JP, et al.MicroRNA-320a suppresses human colon cancer cell proliferation by directly targeting beta-catenin[J]. Biochem Biophys Res Commun, 2012, 420(4): 787-792.
[12]	Baraniskin A,Birkenkamp-Demtroder K,Maghnouj A, et al.MiR-30a-5p suppresses tumor growth in colon carcinoma by targeting DTL[J]. Carcinogenesis, 2012, 33(4): 732-739.
[13]	Shi B,Sepp-Lorenzino L,Prisco M, et al.Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells[J]. J Biol Chem, 2007, 282(45): 32582-32590.
[14]	Luo H,Zou J,Dong Z, et al.Up-regulated miR-17 promotescell proliferation, tumour growth and cell cycle progression by targeting the RND3 tumour suppressor gene in colorectal carcinoma[J]. Biochem J, 2012, 442(2): 311-321.
[15]	Huang Z,Huang S,Wang Q, et al.MicroRNA-95 promotes cell proliferation and targets sorting Nexin 1 in human colorectal carcinoma[J]. Cancer Res, 2011, 71(7): 2582-2589.
[16]	Nie J,Liu L,Zheng W, et al.MicroRNA-365, down-regulated in colon cancer, inhibits cell cycle progression and promotes apoptosis of colon cancer cells by probably targeting Cyclin D1 and Bcl-2[J]. Carcinogenesis, 2012, 33(1): 220-225.
[17]	Zhang H,Li Y,Huang Q, et al.MiR-148a promotes apoptosisby targeting Bcl-2 in colorectal cancer[J]. Cell Death Differ, 2011, 18(11): 1702-1710.
[18]	Nakano H,Miyazawa T,Kinoshita K, et al.Functional screening identifies a microRNA, miR-491 that induces apoptosis bytargeting Bcl-X(L)in colorectal cancer cells[J]. Int J Cancer, 2010, 127(5): 1072-1080.
[19]	Geng L,Zhu B,Dai BH, et al.A let-7/Fas double-negative feedback loop regulates human colon carcinoma cells sensitivity to Fas-related apoptosis[J]. Biochem Biophys Res Commun, 2011, 408(3): 494-499.
[20]	Ma YL,Zhang P,Wang F, et al.Human embryonic stem cells and metastatic colorectal cancer cells shared the common endogenous human microRNA-26b[J]. J Cell Mol Med, 2011, 15(9): 1941-1954.
[21]	Grady WM,Parkin RK,Mitchell PS, et al.Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer[J]. Oncogene, 2008, 27(27): 3880-3888.
[22]	Chen ML,Liang LS,Wang XK.miR-200c inhibits invasion and migration in human colon cancer cells SW480/620 by targeting ZEB1[J]. Clin Exp Metastasis, 2012, 29(5): 457-469.
[23]	Wernicke AG,Shamis M,Sidhu KK, et al.Complication Rates in Patients With Negative Axillary Nodes 10 Years After Local Breast Radiotherapy After Either Sentinel Lymph Node Dissection or Axillary Clearance[J]. Am J Clin Oncol, 2011 Nov 29.[Epub ahead of print]
[24]	Liu X,Zhang Z,Sun L, et al.MicroRNA-499-5p promotes cellular invasion and tumor metastasis in colorectal cancer by targeting FOXO4 and PDCD4[J]. Carcinogenesis, 2011, 32(12): 1798-1805.
[25]	Asangani IA,Rasheed SA,Nikolova DA, et al.MicroRNA-21(miR-21)post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer[J]. Oncogene, 2008, 27(15): 2128-2136.
[26]	Han HB,Gu J,Zuo HJ, et al.Let-7c functions as a metastasis suppressor by targeting MMP11 and PBX3 in colorectal cancer[J]. J Pathol, 2012, 226(3): 544-555.
[27]	Arndt GM,Dossey L,Cullen LM, et al.Characterization ofglobal microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer[J]. BMC Cancer, 2009, 9: 374.
[28]	Sundaram P,Hultine S,Smith LM, et al.P53-responsive miR-194 inhibits thrombospondin-1 and promotes angiogenesis in colon cancers[J]. Cancer Res, 2011, 71(24): 7490-7501.
[29]	Fang JH,Zhou HC,Zeng C, et al.MicroRNA-29b suppresses tumor angiogenesis, invasion, and metastasis by regulat- ing matrix metalloproteinase 2 expression[J]. Hepatology, 2011, 54(5): 1729-1740.
[30]	Valeri N,Gasparini P,Fabbri M, et al.Modulation of mismatch repair and genomic stability by miR-155[J]. Proc Natl Acad Sci U SA, 2010 A, 107(15): 6982-6987.
[31]	Iliopoulos D,Jaeger SA,Hirsch HA, et al.STAT3 activation ofmiR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer[J]. Mol Cell, 2010, 39(4): 493-506.
[32]	Xu XT,Xu Q,Tong JL, et al.MicroRNA expression profiling identifies miR-328 regulates cancer stem cell-like SP cells in colorectal cancer[J]. Br J Cancer, 2012, 106(7): 1320-1330.
[33]	Kurokawa K,Tanahashi T,Iima T, et al.Role of miR-19b andits target mRNAs in 5-fluorouracil resistance in colon cancer cells[J]. J Gastroenterol, 2012 Mar 1.[Epub ahead of print]
[34]	Boni V,Bitarte N,Cristobal I, et al.miR-192/miR-215 influence5-fluorouracil resistance through cell cycle-mediated mechanisms complementary to its post-transcriptional thymidilate synthase regulation[J]. Mol Cancer Ther, 2010, 9(8): 2265-2275.
[35]	Liu K,Li G,Fan C, et al.Increased expression of microRNA-21and its association with chemotherapeutic response in human colorectal cancer[J]. J Int Med Res, 2011, 39(6): 2288-2295.
[36]	Tong JL,Zhang CP,Nie F, et al.MicroRNA 506 regulates expression of PPAR alpha in hydroxycamptothecin-resistant human colon cancer cells[J]. FEBS Lett, 2011, 585(22): 3560-3568.
[37]	Ng EK,Chong WW,Jin H, et al.Differential expression of microRNAs in plasma of patients with colorectal cancer：a potential marker for colorectal cancer screening[J]. Gut, 2009, 58(10): 1375-1381.
[38]	Link A,Balaguer F,Shen Y, et al.Fecal MicroRNAs as novel biomarkers for colon cancer screening[J]. Cancer Epidemiol Biomarkers Prev, 2010, 19(7): 1766-1774.
[39]	Schetter AJ,Leung SY,Sohn JJ, et al.MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma[J]. JAMA, 2008, 299(4): 425-436.
[40]	Pichler M,Winter E,Stotz M, et al.Down-regulation of KRAS-interacting miRNA-143 predicts poor prognosis but not response to EGFR-targeted agents in colorectal cancer[J]. Br J Cancer, 2012, 106(11): 1826-1832.
[41]	Yamashita S,Yamamoto H,Mimori K, et al.MicroRNA-372 IsAssociated with Poor Prognosisin Colorectal Cancer[J]. Oncology, 2012, 82(4): 205-212.
[42]	[Nishida N,Yokobori T,Mimori K, et al.MicroRNA miR-125b is a prognostic marker in human colorectal cancer[J]. Int J Oncol, 2011, 38(5): 1437-1443.
[43]	Tsuchida A,Ohno S,Wu W, et al.miR-92 is a key oncogenic component of the miR-17-92 cluster in colon cancer[J]. CancerSci, 2011, 102(12): 2264-2271.
[44]	Ibrahim AF,Weirauch U,Thomas M, et al.MicroRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinoma[J]. Cancer Res, 2011, 71(15): 5214-5224.

Please choose a citation manager

Content to export